UKMedLab22
BD 12:40 – 13:05
Room: Carlton Room
Topic name: How to improve the detection and management of bloodstream infections (BSI)
Topic overview: Join us as the BD Professional Services team discuss how a shift in your approach to bloodstream infection (or BSI) detection could help you impact your BSI testing pathway to ultimately improve specimen quality, time to detection and time to appropriate treatment.
Sebia 12:40 – 13:15
Room: Grosvenor Room
Topic name: Sebia FLC assays, a fresh approach for serum light chain analysis correcting mistakes of the past
Topic overview: Literature based review of the benefits of Sebia FLC assays including improvements vs existing methodologies
Speaker: Derek Pugh, Sebia UK Ltd
Binding Site 13:25 – 13:55
Room: Alie Room
Topic name: The Hevylite assay and its utility in monitoring multiple myeloma
Topic overview: The Hevyliteassay is a unique automated method for quantifying intact immunoglobulin paraproteins that overcomes limitations of electrophoretic methods and provides a highly sensitive measure of disease activity, thus providing a more accurate measure of response andearlier detection of relapse.
Speaker: Tanja Farrokh, Field Medical Science Liaison, The Binding Site Group Ltd.
Abbott 12:45 – 13:30
Room: Elizabeth Room
Topic name: Integrated Clinical Pathway Transformation with Digital Clinical Decision Support –featuring NHS case study
Topic overview: Learn how your organisation can readily transform data-driven diagnostic care pathways and can impact big health problems, through harnessing the power of data and expertise from their Pathology Service.
Clinical care pathways are transforming dramatically; integrated care system working and the COVID-19 pandemic have widened access to digital technologies across NHS service delivery.
In this presentation, Abbott have invited University Hospitals Birmingham NHS Foundation Trust to share their experience of delivering an innovative transformation of the Liver Conditions pathway with AlinIQ CDS automated clinical decision support technology, and the measurably better patient outcomes that have followed. This experience includes using innovative approaches to supplement current clinical assessment processes, underpinned by changes and efficiencies in pathways, workforce and data collection.
Speaker: Elaine Murphy, Digital Health Solution Manager, Core Diagnostics at Abbott and Dr Rachel Webster, Consultant Clinical Scientist, UHB